← back to search

Silvio Garattini

Mario Negri Institute for Pharmacological Research · IT
🔎 Find collaborators in Cellular and Molecular Neuroscience · Economics and Econometrics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cellular and Molecular Neuroscience · Economics and Econometrics
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Health Systems, Economic Evaluations, Quality of Life, and Receptor Mechanisms and Signaling.
h-index
77
citations
26,325
works
1,104
NIH funding
primary concept
email

Recent publications

Paving the way towards medicines for women and men.
2024cited by 0position: contributordoi
An Italian Consensus Conference on Psychological Therapies for Anxiety and Depression.
2024cited by 0position: contributordoi
High-energy devices in different surgical settings: lessons learnt from a full health technology assessment report developed by SICE (Società Italiana di Chirurgia Endoscopica).
2023cited by 3position: contributordoi
Switching Among Biosimilars: A Review of Clinical Evidence.
2022cited by 24position: contributordoi
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
2022cited by 11position: contributordoi
Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications.
2022cited by 9position: contributordoi
<i>HER2-CDH1</i> Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric Adenocarcinoma.
2022cited by 8position: contributordoi
Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review.
2022cited by 7position: contributordoi
Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection.
2022cited by 6position: contributordoi
Analysis of workload generated in the two years following first consultation by each new cancer patient: studying the past to plan the future of cancer care.
2022cited by 4position: contributordoi
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study - protocol for a randomised, multicentre, phase 3 trial.
2022cited by 3position: contributordoi
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice.
2022cited by 3position: contributordoi
Drug treatments and interactions, disease progression and quality of life in ALS patients.
2022cited by 2position: contributordoi
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.
2022cited by 2position: contributordoi
Pseudo-resistance to anticancer drugs.
2022cited by 1position: contributordoi
Scientific and ethical issues in add-on designs for antidiabetic drugs.
2022cited by 0position: contributordoi
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis. Short and long-term outcomes. GOETH STUDY. A collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, SICO
2022cited by 0position: contributordoi
A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents.
2022cited by 0position: contributordoi
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines
Nature Nanotechnology 2021cited by 85position: middledoi
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
2021cited by 59position: contributordoi
Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients' sera.
2021cited by 21position: contributordoi
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
2021cited by 12position: contributordoi
Brain Kynurenine Pathway and Functional Outcome of Rats Resuscitated From Cardiac Arrest.
2021cited by 11position: contributordoi
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
2021cited by 10position: contributordoi
Pharmaceutical Strategy for Europe: Reflections on Public Health-Driven Drug Development, Regulation, and Policies.
2021cited by 6position: contributordoi
Food advertising during children's television programmes in Italy.
2021cited by 5position: contributordoi
State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer.
2021cited by 3position: contributordoi
Quality, efficacy, safety-it is not enough!
2021cited by 2position: contributordoi
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval.
2020cited by 28position: contributordoi
We are more than our omics.
2020cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Edmund Neugebauer · Medizinische Hochschule Brandenburg Theodor Fontane5 papers (2016–2017) · 5 papers (2016–2017)Christian Gluud · Quality of Life Research Center5 papers (2016–2017)Ana Rath · Jackson Laboratory5 papers (2016–2017)Martine Laville · University of Padua5 papers (2016–2017)Janus Christian Jakobsen · University of Southern Denmark5 papers (2016–2017) · 5 papers (2016–2017) · 4 papers (2017–2017)Fabio Puglisi · Cancer Institute (WIA)4 papers (2021–2022)Christine Kubiak · European Clinical Research Infrastructure Network4 papers (2017–2017)Gianmaria Miolo · Prevention Institute3 papers (2021–2022)Virginie Hivert · Université Claude Bernard Lyon 13 papers (2016–2017)M. Hiesmayr · University of Nevada, Las Vegas2 papers (2017–2017)Bérénice Segrestin · Université Claude Bernard Lyon 12 papers (2017–2017) · 2 papers (2016–2017)Mario Scartozzi · Policlinico Casilino2 papers (2021–2022)Silvio Ken Garattini · Azienda Sanitaria Universitaria Integrata di Udine2 papers (2021–2022)Roberto Latini · Istituti di Ricovero e Cura a Carattere Scientifico2 papers (2021–2022)Sara Lonardi · Nouscom (Italy)2 papers (2021–2022)Miriam Lichtner · Servizio Sanitario Nazionale2 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cellular and Molecular Neuroscience · Economics and Econometrics →